Lv2
158 积分 2025-03-26 加入
Gemcitabine-facilitated modulation of the tumor microenvironment and PD-1/PD-L1 blockade generate a synergistic antitumor effect in a murine hepatocellular carcinoma model
2小时前
待确认
AP1M2 Drives Gemcitabine‐Cisplatin Chemoresistance by Enhancing RAD54B‐Associated DNA Repair in Bladder Cancer
2小时前
已完结
Assessment of Therapeutic Effects of Combined Treatment With Cisplatin and Anti-mouse Programmed Death (PD)-1 Antibody in a Mouse Urothelial Cancer Model
2小时前
求助中
Advances in diagnosis and treatment of bladder cancer
3天前
已完结
Neoadjuvant immunotherapy for muscle-invasive bladder cancer: a 2025 update
3天前
已完结
Inhibition of tumor cell macropinocytosis driver DHODH reverses immunosuppression and overcomes anti-PD1 resistance
21天前
已完结
Chapter 5 - BBN-driven urinary bladder cancer mouse model
1个月前
已完结
Establishing a Murine Superficial Bladder Cancer Model <em>via</em> an Intravesical Cell Administration Technique
1个月前
已完结
The combination therapy of Everolimus and anti-PD-1 improves the antitumor effect by regulating CD8+ T cells in bladder cancer
1个月前
已完结
Effects of temozolomide on tumor mutation burden and microsatellite instability in melanoma cells
1个月前
已完结
皖公网安备34019202002308
